Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy-Reference-Cited by-同舟云学术

Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy

Published:2010-08-20 Issue:9 Volume:1 Page:488-492
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Chekler Eugene L. Piatnitski¹,Kiselyov Alexander S.¹,Ouyang Xiaohu¹,Chen Xiaoling¹,Pattaropong Vatee¹,Wang Ying²,Tuma M. Carolina²,Doody Jacqueline F.²

Affiliation:

1. Department of Chemistry

2. Department of Cell Biology

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml1001568

Reference14 articles.

1. Microtubule assembly dynamics: new insights at the nanoscale

2. Microtubules as a target for anticancer drugs

3. Antiangiogenic Agents: an Update on Small Molecule VEGFR Inhibitors

4. Wedge, S. R.; Kendrew, J.; Ogilvie, D. J.; Hennequin, L. F.; Brave, S. R.; Ryan, A. J; Ashton, S. E.; Calvete, J. A.; Blakey, D. C.Combination of the VEGF receptor tyrosine kinase inhibitor ZD6474 and tubulin agent ZD6126 produces an enhanced anti-tumor response.American Association for Cancer Research, Annual Meeting, 2002; Poster 5351.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity;Bioorganic Chemistry;2024-10

2. Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity;Bioorganic Chemistry;2023-10

3. Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy;Current Molecular Pharmacology;2023-08-10

4. Synthesis of Some New Indole-1,3,4-Oxadiazole Hybrids as Tubulin Polymerization Inhibitors;Russian Journal of Bioorganic Chemistry;2022-12

5. Synthesis of new 1,3,4-oxadiazole-1,4-benzoxazinone hybrids as tubulin polymerization inhibiting anticancer agents and their in silico studies;Tetrahedron;2022-10